Mind Medicine (MNMD) Misses Q2 EPS by 13c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• UBS Downgrades Core Natural Resources (CNR) to Neutral
• Mercury Systems (MRCY) Misses Q4 EPS by 2c